Emphasising that early detection and affordability are the two biggest challenges in addressing genetic and rare diseases, ...
Emphasising that early detection and affordability are the biggest challenges in addressing genetic and rare diseases, ...
The partnership between the American University in Cairo (AUC) and Minapharm Pharmaceuticals, which gets underway early this year, will contribute to establishing what the university describes as the ...
The EU-Mercosur deal has been signed. The free trade agreement will remove numerous tariff barriers between the EU and the ...
Press release – No. 2 / 2026Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support ...
Singaporean cultivated seafood producer UMAMI Bioworks has signed a Memorandum of Understanding (MoU) with Nippon Barrier ...
Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...
The Citizen on MSN
Samia tasks marine scholars to drive blue economy agenda
President Hassan says the blue economy remains one of the country’s most strategic development pillars—both for people’s ...
H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune DiseaseInterim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with ...
Zhu Wei, an associate professor at China University of Political Science and Law, said livestreaming e-commerce is expanding ...
Binge-watching Mad Men sparks reflections on nostalgia, AI, remote work, and how technology reshapes human life.
Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that China's National Medical Products Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback